MedTrace Logo

Trans-nasal Endoscopy for Bariatric Patients

NCT06200961 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-02

No results posted yet for this study

Summary

This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.

Conditions

  • Obesity
  • Obesity, Morbid
  • Obese
  • GI Disorders
  • Gastrointestinal Diseases

Interventions

DEVICE

Transnasal Endoscopy

Unsedated endoscopic evaluation through the nose.

PROCEDURE

Esophagogastroduodenoscopy

Sedated endoscopic evaluation through the mouth.

Sponsors & Collaborators

  • EvoEndo, Inc.

    collaborator UNKNOWN

  • Christopher C. Thompson, MD, MSc

    lead OTHER

Principal Investigators

  • Christopher C. Thompson, MD, MSc · Brigham and Womens Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-06-30
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06200961 on ClinicalTrials.gov